Latest Industry Insights

In bioanalysis, AI could alleviate preclinical and clinical bioanalytical data processing and analysis. Here, Mary Belfast from Teva Branded Pharmaceuticals, discusses some of the latest guidelines on AI implementation and validation in bioanalysis.

Technology Networks joined Agilent Technologies for a discussion about new advances in gas chromatography at this year’s ASMS conference.

We sat down with Dr. John Puglia, senior director of research and development at Thermo Fisher, to learn more about their new biobased films and other sustainability initiatives.

In this interview, we spoke to Jason Koth, product management lead at Scale Biosciences, to learn more about their new ScalePlex technology for leveraging and overcoming current limitations within single-cell genomics.

In this interview, Dr. Becky Upton discusses the key findings of a recent survey conducted by the Pistoia Alliance regarding the use of AI in life sciences and the main hurdles preventing wider adoption of AI in pharma.

In this article, Michelle Fraser and Amanda Haupthow discuss how engineered nucleases in combination with next-generation base editing platforms are paving the way for the development of novel treatments for genetic disorders and diseases.

In this interview, Tola Olorunnisola, senior vice president and general manager at Avantor, delves into how AI and automation could put the Lab of the Future within our grasp, enabling scientific breakthroughs and revolutionizing the drug development process.

In this interview, Technology Networks spoke to Dr. Martin Vollmer, biopharma program manager within the Life Science Analysis Group at Agilent, to learn about the current analytical challenges the biopharma industry faces and how they are being addressed.

Elsevier’s “Insights 2024: Attitudes toward AI” report reveals how researchers feel about AI and what is needed to increase trust in these tools. Here, Mirit Eldor, managing director, life sciences at Elsevier discusses these findings further.

Western blotting is a staple technique in many laboratories but can be time consuming and inconsistent. Technology Networks spoke with Harsha Rao to learn more about Stain-Free western blotting and the advantages of total protein normalization.